Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
FEBS Letters|April 20, 2001
Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cellsO Grobe, A Arlt, H Ungefroren, et al.
Leukemia|August 13, 2004
The expression of immediate early gene X-1 (IEX-1) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cellsA Arlt, J Minkenberg, B Kocs, et al.
Oncogene|April 21, 2001
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicinA Arlt, J Vorndamm, M Breitenbroich, et al.
The Journal of Infectious Diseases|July 7, 2011
Induction of human β-defensins and psoriasin in vulvovaginal human papillomavirus-associated lesionsW Erhart, Ö Alkasi, G Brunke, et al.
Endoscopy|June 20, 2013
Prospective evaluation of malignant cell seeding after percutaneous endoscopic gastrostomy in patients with oropharyngeal/esophageal cancersM Ellrichmann, P Sergeev, J Bethge, et al.
Oncogene|October 31, 2012
Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activityA Arlt, S Sebens, S Krebs, et al.
Oncogene|March 13, 2001
Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cellsA Arlt, O Grobe, A Sieke, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 5, 2008
Fatal pneumocystis jirovecii pneumonia in a case of ectopic Cushing's syndrome due to neuroendocrine carcinoma of the kidneyA Arlt, B Harbeck, M Anlauf, et al.
Journal of Cell Science|October 31, 2001
FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosisH Ungefroren, M L Kruse, A Trauzold, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 7, 2002
Thrombin as a survival factor for cancer cells: thrombin activation in malignant effusions in vivo and inhibition of idarubicin-induced cell death in vitroH Schiller, T Bartscht, A Arlt, et al.
Pageof 6